CAP accreditation, widely recognized as the gold standard in laboratory quality assurance, complements CNSide Diagnostics' ...
Plus Therapeutics Inc (NASDAQ:PSTV) said its CNSide Diagnostics unit has received accreditation from the College of American ...
An Edinburgh-based brain health company has launched Scotland’s first publicly available laboratory testing to support ...
An Edinburgh-based brain health company has launched Scotland’s first publicly available laboratory testing to support earlier Alzheimer's ...
Plus and Harvard analysis shows CNSide enables early diagnosis and better clinical decision-making reducing healthcare costs by 40%. Presentation receives blue-ribbon recognition ...
Mamamia on MSN
Your 5-minute news explainer to get you up to date today
The news moves fast and so do we.The Quicky is Mamamia's daily news podcast, getting you up to speed on all the latest news ...
Research from the University of Florida, Mayo Clinic, and Vanderbilt University, in collaboration with the Parkinson's ...
Detailed price information for Plus Therapeutics Inc (PSTV-Q) from The Globe and Mail including charting and trades.
Roche’s Plasma p-Tau217 Testing as a Research Standard for Early Alzheimer’s Detection in Metabolically High-Risk Patients ...
Alzheimer's is the most common form of dementia, accounting for 60-70% of cases, and is growing at a scale that is still not fully reckoned with. In 2019, an estimated 57 million people worldwide were ...
First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline –– Announced FDA Approval of VEPPANU™ ...
A man in his 50s with poorly controlled diabetes and chronic kidney disease presented with rapidly progressive bilateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results